Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
BACK
Your are on :   Markets   |  IPO   |  IPO SynopsisAs on: Jul 16,2025 02:01 PM
Sotac Pharmaceuticals Ltd
Registered Office: Plot No PF-21 Nr ACME Pharma,Opp Teva Pharma Sanand GIDC-II, Ahmedabad - 382110, Gujarat, India.
Phone : 91-90819 93300   Fax:
Email :  compliance@sotacpharma.com  
Website :  www.sotacpharma.com
Initial public issue of 3000000 equity shares of face value of Rs. 10/- each of Sotac Pharmaceuticals Limited ("SPL" or the "Company" or the "Issuer") for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share (the "Issue Price") aggregating to Rs. 33.30 crores ("The Issue"), of which 150000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share aggregating to Rs. 1.67 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 2850000 equity shares of face value of Rs. 10/- each at a price of Rs. 111/- per equity share including a share premium of Rs. 101/- per equity share aggregating to Rs. 31.63 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 27.15% and 25.79%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each.
Issue Money Payable On
Opens On Closes On Application Allotment
29-Mar-23 03-Apr-23 111.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 1200   Further Multiples of : 1200
  (Rs) Lead Managers to the Issue
Project Cost 31.10 Beeline Capital Advisors Pvt Ltd
Project Financed through Current Offer 33.30  
Post Issue Equity Share Capital 11.05  
Issue Price 111.00  
Projects
To meet working capital requirements Investment in subsidiary
Upgradation/construction of existing /new building in the existing premises General corporate purposes
Promoted By
Sharadkumar Dashrathbhai Patel
Dineshkumar Babulal Gelot
Vishalkumar Devrajbhai Patel
Listing At
NSE - SME
Registrar to the Issue
No Data Available
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)